Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8567675rdf:typepubmed:Citationlld:pubmed
pubmed-article:8567675lifeskim:mentionsumls-concept:C0085828lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C0025255lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C0018042lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C0033684lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1511625lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C0108555lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1416952lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1519063lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1510827lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1879748lld:lifeskim
pubmed-article:8567675lifeskim:mentionsumls-concept:C1706853lld:lifeskim
pubmed-article:8567675pubmed:issue4lld:pubmed
pubmed-article:8567675pubmed:dateCreated1996-3-1lld:pubmed
pubmed-article:8567675pubmed:abstractTextThe transport of proteins from the secretory to the endocytic pathway is mediated by carrier vesicles coated with the AP-1 Golgi assembly proteins and clathrin. The mannose 6-phosphate receptors (MPHs) are two major transmembrane proteins segregated into these transport vesicles. Together with the GTPase ARF-1, these cargo proteins are essential components for the efficient translocation of the cytosolic AP-1 onto membranes of the trans-Golgi network, the first step of clathrin coat assembly, MPR-negative fibroblasts have a low capacity of recruiting AP-1 which can be restored by re-expressing the MPRs in these cells. This property was used to identify the protein motif of the cation-dependent mannose 6-phosphate receptor (CD-MPR) cytoplasmic domain that is essential for these interactions. Thus, the affinity of AP-1 for membranes and in vivo transport of cathepsin D were measured for MPR-negative cells re-expressing various CD-MPR mutants. The results indicate that the targeting of lysosomal enzymes requires the CD-PDR cytoplasmic domain that are different from tyrosine-based endocytosis motifs. The first is a casein kinase II phosphorylation site (ESEER) that is essential for high affinity binding of AP-1 and therefore probably acts as a dominant determinant controlling CD-MPR sorting in the trans-Golgi network. The second is the adjacent di-leucine motif (HLLPM), which, by itself, is not critical for AP-1 binding, but is absolutely required for a downstream sorting event.lld:pubmed
pubmed-article:8567675pubmed:languageenglld:pubmed
pubmed-article:8567675pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:citationSubsetIMlld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8567675pubmed:statusMEDLINElld:pubmed
pubmed-article:8567675pubmed:monthJanlld:pubmed
pubmed-article:8567675pubmed:issn0021-9258lld:pubmed
pubmed-article:8567675pubmed:authorpubmed-author:HoflackBBlld:pubmed
pubmed-article:8567675pubmed:authorpubmed-author:MauxionFFlld:pubmed
pubmed-article:8567675pubmed:authorpubmed-author:Le BorgneRRlld:pubmed
pubmed-article:8567675pubmed:authorpubmed-author:Munier-Lehman...lld:pubmed
pubmed-article:8567675pubmed:issnTypePrintlld:pubmed
pubmed-article:8567675pubmed:day26lld:pubmed
pubmed-article:8567675pubmed:volume271lld:pubmed
pubmed-article:8567675pubmed:ownerNLMlld:pubmed
pubmed-article:8567675pubmed:authorsCompleteYlld:pubmed
pubmed-article:8567675pubmed:pagination2171-8lld:pubmed
pubmed-article:8567675pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:meshHeadingpubmed-meshheading:8567675-...lld:pubmed
pubmed-article:8567675pubmed:year1996lld:pubmed
pubmed-article:8567675pubmed:articleTitleA casein kinase II phosphorylation site in the cytoplasmic domain of the cation-dependent mannose 6-phosphate receptor determines the high affinity interaction of the AP-1 Golgi assembly proteins with membranes.lld:pubmed
pubmed-article:8567675pubmed:affiliationEuropean Molecular Biology Laboratory, Heidelberg, Federal Republic of Germany.lld:pubmed
pubmed-article:8567675pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8567675pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8567675lld:pubmed
More...